Somatic cell nuclear transfer (SCNT) has generally demonstrated that a differentiated cell can convert into a undifferentiated or pluripotent state. In the SCNT experiment, nuclear reprogramming is induced by exposure of introduced donor nuclei to the recipient cytoplasm of matured oocytes. However, because the efficiency of SCNT still remains low, a combination of SCNT technique with the ex-ovo method may improve the normal development of SCNT embryos. Here we hypothesized that treatment of somatic cells with extracts prepared from the germinal vesicle (GV) stage Siberian sturgeon oocytes prior to their use as nuclear donor for SCNT would improve in vitro development. A reversible permeability protocol with 4 μg/mL of digitonin for 2 min at 4°C in order to deliver Siberian sturgeon oocyte extract (SOE) to porcine fetal fibroblasts (PFFs) was carried out. As results, the intensity of H3K9ac staining in PFFs following treatment of SOE for 7 h at 18°C was significantly increased but the intensity of H3K9me3 staining in PFFs was significantly decreased as compared with the control (p<0.05). Additionally, the level of histone acetylation in SCNT embryos at the zygote stage was significantly increased when reconstructed using SOE-treated cells (p<0.05), similar to that of IVF embryos at the zygote stage. The number of apoptotic cells was significantly decreased and pluripotency markers (Nanog, Oct4 and Sox2) were highly expressed in the blastocyst stage of SCNT embryos reconstructed using SOE-treated cells as nuclear donor (p<0.05). And there was observed a better development to the blastocyst stage in the SOE-treated group (p<0.05). Our results suggested that pre-treatment of cells with SOE could improve epigenetic reprogramming and the quality of porcine SCNT embryos.
During development, embryonic cells undergo a series of processes such as modifications of nuclear and chromatin structure and give rise to specific cell types of an organism. Acquisition and maintenance of the differentiation state can be stably inherited through cell division and proliferation whereas reversion of a differentiated cell to an undifferentiated or pluripotency cell state is strictly inhibited in normal development (Jouneau and Renard, 2003). Such direct conversion would be a promising approach for animal biotechnology and regenerative medicine.
The ability to reprogram differentiated somatic cells was first demonstrated in mammals by the generation of animals after somatic cell nuclear transfer (SCNT) (Wilmut et al., 1997; Wakayama et al., 1998), and followed by the generation of pluripotent stem cells from terminally differentiated fibroblast cells by retroviral transduction of defined pluripotent transcription factors (Takahashi et al., 2006). Recently, alternative approaches to reprogramming of differentiated somatic cells into an embryonic pluripotent state have been developed as cellular fusion (Tada et al., 1997; Blasu et al., 1999), the use of cell or oocyte extract (Alberio et al., 2005; Taranger et al., 2005; Bian et al., 2009) and culture-induced reprogramming (Konrad and Rudolf, 2006).
Even though the SCNT-derived offspring have been successfully produced in all mammalian species, the efficiency of development to term is still low. It was continually reported that most of cloned offspring produced by SCNT technique show rudimentary figures or abnormalities (Tang et al., 2009; Rathbone et al., 2010). One of the reasons causing these problems is incomplete or incorrect reprogramming of somatic nucleus following introduced into the recipient cytoplasm, giving rise to epigenetic defects (Morgan et al., 2005). With the purpose of solving these problems several researches have been developed favourable reprogramming of donor nuclei by means of some extrinsic factors before exposure to the recipient environment.
The ex-ovo system for epigenetic reprogramming of a terminately differentiated cell depends on the transient uptake of regulatory components from a nuclear and cytoplasmic mixtures derived from cell extract (Håkelien et al., 2002; Landsverk et al., 2002). In the pioneering studies with amphibians and mammals, it was demonstrated that epigenetic reprogramming of differentiated mammalian cells were successfully induced to a pluripotent state by exposing amphibian oocyte extracts (Hochedilinger et al., 2002; Alberio et al., 2005; Bian et al., 2009). When ovine SCNT embryos reconstructed by using donor cells pretreated with Xenopus laevis germinal vesicle (GV) oocyte extracts were transferred into surrogate, the pregnancy and survival rate were greatly improved (Rathbone et al., 2010). Miyamoto et al. (2007) has been reported that porcine metaphase (MII) oocyte extract replaces transcription factors from donor nuclei with the oocyte extract and eventually increases the histone deacetylation in the somatic nuclei. It has been reported that the transcriptional reprogramming of human and bovine nuclei increased after treatment of cells in extracts from Xenopus laevis oocytes or egg (Hansis et al., 2004; Alberio et al., 2005). Furthermore, these cells showed up-regulation in the expression of pluripotency markers (Oct4, Sox2, and Nanog) and formed outgrowth colonies which similar with morphology of embryonic stem cells (ESCs) (Miyamoto et al., 2008).
As mentioned above, the use of totipotent or pluripotent cell extract for pre-treatment of donor cells prior to SCNT has been expected to improve epigenetic reprogramming of cloned embryos and eventually enhance the frequency of development to term. Due to the limitation in accessibility of mammalian oocytes, non-mammalian eggs the large number and volume would be a tempting alternative. In generally, Xenopus laevis oocytes at the germinal vesicle (GV) stage are extremely larger than mammalian oocytes and accessible with relative ease. Like Xenopus laevis oocytes, a Siberian sturgeon spawns approximately hundreds of thousand oocytes at a time and the size of a sturgeon oocyte is excessively lager than that of a mammalian oocyte (approximately 4.0 mm in diameter) (Campman and Van Eenennaam, 2007). Therefore, Siberian sturgeon oocyte can be a good source to study the molecular mechanisms underlying epigenetic reprogramming. So far, no one has ever studied using ichthyic oocyte extract for epigenetic reprogramming of mammalian species, which might be worth studying. Thus, we used the oocyte extract of Siberian sturgeon to alter the epigenetic modifications such as DNA methylation and histone acetylation in the nuclei of porcine somatic cells. Finally, the effects of pre-treatment of donor cells with the oocyte extract prior to SCNT on the subsequent development of porcine SCNT embryo were determined.
MATERIALS AND METHODS
All chemicals were purchased from Sigma-Aldrich Company (St. Louis, MO, USA) unless otherwise stated.
Collection and culture of porcine oocyte
Porcine ovaries were collected at a local slaughterhouse and transported to the laboratory in PBS at 39°C. Cumulus-oocyte complexes (COCs) were aspirated from 2 to 5 mm of antral follicles in diameter using 18-gauge needle. Good-quality oocytes surrounded by at least three layers of cumulus cells were selected in TL-HEPES buffer. Oocyte were washed three times in Bicarbonate-buffered TCM 199 (Gibco) supplemented with 10% PVA, 3.05 mM D-glucose, 0.91 mM Na-pyruvate, 0.57 mM Cysteine, 75 μg/mL Penicillin, 50 μg/mL Streptomycin, 10 ng/mL EGF, 1 μg/mL FSH, 5 μg/mL LH. Porcine COCs were initially washed twice in 13 mM Brilliant Cresyl Blue (BCB) medium supplemented with 4 mg/mL BSA and incubated for 90 min at 39°C in humidified atmosphere of 5% CO2. Following exposure to BCB, only COCs stained blue color were selected for oocyte maturation under a stereomicroscope. To synchronize meiotic maturation, COCs were pre-incubated in maturation medium supplemented with 5 μg/mL of CHXM for 16h (Ye et al., 2002). Following treatment with CHXM, the COCs then washed thoroughly washed in maturation medium and further cultured without CHXM. All culture drops containing oocytes were covered with a thin layer of mineral oil pre-equilibrated with medium and incubated in 5% CO2 in humidified air at 39°C.
In vitro fertilization
The diluted porcine semen was transported to the laboratory. After washing once by centrifugation at 750 g for 3 min, spermatozoa were resuspended at a concentration of 1×108 cells. Cumulus cells were removed from COCs by pipetting for several times in TL-hepes with 0.1% (w/v) hyaluronidase. Groups of 15 oocytes were then incubated in a concentration of 5×105 sperm/ml of PZM5 medium supplemented with 20 mL/L BME amino acids, 10 mL/L MEM-nonessential amino acids, 3 mg/mL BSA (fatty acid free) and cultured at 39°C in 5% O2, 5% CO2. On day 2, cleaved embryos were transferred into fresh PZM5 medium until the blastocyst stage.
Preparation of porcine fetal fibroblasts
Porcine fetal fibroblasts (PFFs) were isolated from 30 day old fetus and cultured for a 4 to 5 passages in DMEM containing 1.25% MEM-nonessential amino acids, 1.25% β-mercaptoethanol, 1% penicillin/streptomycin supplemented with 10% FBS at 39°C in 5% CO2. Primary cultures were then stored in liquid nitrogen until used. Cells were thawed and then cultured until 80% confluent. PFFs for SCNT were synchronized at the G0 stage by 3–5 ays in the DMEM supplemented with 0.1% FBS.
Permeabilization and cell viability of PFFs treated with digitonin
Permeabiliszation and cell viability of PFFs treated with digitonin were assessed by 0.8 mM trypan blue solution for 1 day. The cells were divided into two groups; trypan blue+ (colored nucleus; permeable membrane) and trypan blue- (colorless nucleus; non permeable membrane).
Preparation of Siberian sturgeon oocyte extract
In the spring, Siberian sturgeon oocytes were collected from mature females and then removed jelly coat in collagenase solution (8 mg/mL type II collagenase in Ca2+ free Ringers solution) for 30 min. After dejellying, the oocytes were washed three times in Ringer’s buffer and then necrotic oocytes were removed (Campman and Van Eenennaam, 2007). Only good quality oocytes were collected in tubes and rinsed three times in ice cold extraction buffer (20 mM Hepes [pH 7.5], 100 mM KCl, 5 mM MgCl2) added protease inhibitors (2 mM β-Mercaptoethanol, 3 μg/mL Leupeptin, 1 μg/mL Aprotinin, 1 μg/mL Pepstatin A). The oocytes were moved into centrifuge tubes (Beckman, USA) and centrifuged at 10,000 g for 15 min at 4°C using an ultracentrifuge (Optima XL-100K, Beckman). These steps were performed for several times. The middle layer was taken and recentrifuged at 100,000 g for 30 min at 4°C. These steps were also performed for several times. The collected cytoplasm was supplemented with 5% glycerol and stored at liquid nitrogen until used.
Incubation of PFFs with Siberian sturgeon oocyte extract
PFFs were trypsinized and then permeabilized with 4 μg/mL of digitonin in PB buffer (170 mM potassium gluconate, 5 mM KCl, 2 mM MgCl2, 1 mM KH2PO4, 1 mM EGTA, 20 mM HEPES) supplemented with 2 mM DTT, 3 μg/mL Leupeptin, 1 μg/mL Aprotinin and 1 μg/mL Pepstatin A (pH 7.25) for 2 min at 4°C. Following treatment with digitonin 10 mL of PB buffer was added and then centrifuged at 700×g for 10 min at 4°C. The permeabilized cells by digitonin were exposed to SOE for 7 h at 15°C to 18°C with agitation every hour. After incubation with SOE, cells were centrifuged in the permeabilization buffer.
Immunocytochemistry for DNA methylation and histone acetylation
After treatment of SOE, PFFs were placed onto a cover slip by centrifuge (Centurion Scientific Ltd, UK), fixed 4% paraformaldehyde solution for 15 min and then washed three times with PBS-T (0.1% Tween 20, and 7.7 mM sodium azide in PBS) for 5 min. These cells were blocked with blocking solution (5% BSA in PBS-T) for 1 h at room temperature and then incubated in the primary antibody: Histone H3 Lys-9 methylation (H3K9me3, 1:250, Abcam, UK) or Histone H3 Lys-9 acetylation (H3K9ac, 1:250, Milipore, USA) for overnight at 4°C. After incubation with the primary antibody these cells were washed three times with PBS-T for 5 min. The secondary antibody was followed: Alexafluor 488 goat anti-rabbit IgG (1:150, Invitrogen, USA) for 1 h at room temperature. Nucleus of cells were stained with propidium lodide (0.5 μL/mL in PBS) for 10 min at room temperature and mounted with VECTASHIELD (Vector Laboratories, Inc, USA). Images were captured a fluorescence microscope (LEICA DM 2500, Switzerland). On the other hand, porcine embryos were fixed 4% paraformaldehyde solution for 1 h and then washed three times with PBS-T. After being washed embryos were permeabilized with 0.5% Triton X-100 in PBS for 30 min at 4°C and then washed three times. These embryos were blocked in blocking solution for overnight at 4°C. They were then incubated in the primary antibody: H3K9ac (1:300, Milipore) for 1 h at 37°C and washed several times in PBS-T. Embryos were followed by incubated with the secondary antibody: Alexafluor 488 goat anti-rabbit IgG (1:150, Invitrogen) for 1 h at room temperature without the light. After being washing several times, embryos were stained with propidium lodide (50 pg/mL) for 10 min at room temperature and mounted with VECTASHIELD.
SOE treated cells were fixed with 4% paraformaldehyde solution for 15 min at 4°C. These fixed cells were rinsed in DPBS without Mg2+ and Ca2+, 0.1% PVA and blocked with blocking solution (DPBS without Mg2+ and Ca2+, 0.1% PVA, 1% BSA) for 30 min at 4°C. They were added by the antibody of H3K9ac (1:100, Milipore) or H3K9me3 (1:100, Abcam, UK) for 45 min at 4°C and incubated in the secondary antibody: Alexa fluor 488 goat anti-rabbit IgG (1:500, Invitrogen). Analysis was performed using FACSCalibur (Becton Dickinson, USA).
Reverse-transcription PCR (RT-PCR)
Total RNAs of cells were extracted using an RNeasy Plus mini kit (Quiagen, USA). DNA synthesis was performed for 60 min at 4°C and RTase inactivation was performed for 5 min at 95°C using Maxime RT Premix (iNtRON Biotechnology, Korea). PCR was performed using Maxime PCR Premix (iNtRON Biotechnology) supplemented with 18 μL H2O, 2 μL primers (10 μM) and sample 2 μL. The conditions of RT-PCR were followed: predenaturation for 10 min at 95°C, denaturation for 30 min at 94°C, anealing for 30 s at 53.5°C, 57.1°C and 60°C, extinction for 45 s at 72°C and final extension for 10 min at 72°C for 34 cycles using (Pro s6325, Eppendorf). These RT-PCR products were loaded on 2% agarose gels. On the other hands, total RNAs of porcine embryos at the blastocyst stage were extracted using an Absolutely RNA nanoprep kit (Stratagene, USA). DNA synthesis was performed for 60 min at 45°C and RTase inactivation was performed for 5 min at 95°C using a Revoscript RT Premix (iNtRON Biotechnology). PCR was performed using Maxime PCR Premix supplemented with 18 μL H2O, 2 μL primers (10 μM) and sample 2 μL. The conditions of RT-PCR were followed: predenaturation for 10 min at 95°C, denaturation for 30 min at 94°C, anealing for 30 s at 53.3°C, 57.6°C and 64°C, extinction for 45 s at 72°C and final extension for 10 min at 72°C for 34 cycles using (Pro s6325, Eppendorf). These PCR products were loaded on 2% agarose gels. Sequence of primers was listed in Table 1.
Cells treated with SOE were lysed in PRO-PREPTM Solution (iNtRON Biotechnology) for 20 min at −20°C. Proteins extracted from cells were separated on 12% SDS-PAGE gels. Proteins were transferred onto a PVDF membrane using Mimi-PROTEAN Tetra Cell (BIO-RAD, USA). After being treated in the blocking solution (TBS containing 0.1% Tween-20, 5% non-fat dry milk) for 1 h at room temperature, membrane was placed in the primary antibody solution: H3K9ac (1:500, Milipore), H3K9me3 (1:1,000, Abcam) or Histone 3 (H3, 1:5,000, Abcam) for overnight at 4°C. Membrane was rinsed three times for 5 min each with PBS-T (PBS containing 0.1% Tween-20) and incubated in the secondary antibody: Peroxidase conjugated goat anti rabbit (1:5,000, KPL, USA) for 1 h at room temperature. WEST-one (InTRON Biotechnology) was used to detect chemiluminescence.
Somatic cell nuclear transfer (SCNT)
After incubation of CHXM for 16 h, porcine COCs were in vitro matured for further 17 to 18 h. Oocytes were exposed to TL-HEPES buffer containing 0.1% hyaluronidase and then vortexed for 4 to 5 min in order to remove cumulus cells. The denuded oocytes were dyed for 10 min in TCM-199 containing 25 mM HEPES and 1 μg/mL Hoechst 33342 and were then removed the spindle of the first meiotic anaphase/telophase I (AI/TI) in TCM-199 containing 25 mM HEPES and 5 μg/mL cytochalsin B (CB) (Lee and Campbell, 2006). To confirm the enucleation of oocyte, the aspirated karyoplast in the pipette was visualized under fluorescent light. Enucleated oocytes were cultured in TCM-199 supplemented with 10 ng/mL EGF, 0.5 μg/mL FSH and 0.5 μg/mL LH and 5 mM Caffeine for 12 h. After donor cells were transferred into the enucleated oocytes, the reconstructed oocytes were exposed to electric pulse of 1.25 KV/cm for 30 μs in 0.3 M mannitol plus 0.1 mM MgSO4, 0.5 mM CaCl2, 3 mg/mL BSA using a multiporator (Eppendorf, Germany). Fused oocytes were incubated with PZM5 medium at 39°C in an atmosphere of 5% CO2 and 5% O2. On day 2, cleaved embryos were transferred into fresh PZM5 medium until the blastocyst stage.
Apoptotic assay of SCNT embryos
Apoptotic assay of SCNT embryos at the blastocyst stage was performed using In Situ Cell Death Detection Kit (Hoffmann-La Roche Ltd, Switzerland). On Day 7, porcine SCNT embryos were fixed with 4% paraformaldehyde solution for 1 h at 4°C and then rinsed three times with PBS. Samples were treated in the permeabilization buffer (0.1% Triton X-100, 0.1% sodium citrate in PBS) for 2 min on ice. These embryos were washed three times in PBS and then incubated in TUNEL reaction mixture for 60 min at 37°C without the light. After the TUNEL staining, embryos were washed three times and then stained with Hoechst 33342 (50 pg/mL) for 10 min at 39°C. Embryos were mounted with VECTASHIELD (Vector Laboratories, Inc). Images were captured a fluorescence microscope (LEICA DM 2500).
Effects of digitonin treatment on membrane permeabilization and viability of PFFs
The plasma membrane of porcine fetal fibroblast cells (PFFs) should be permeable to allow transport of unique oocyte factors existed in Siberian sturgeon oocyte extracts (SOE) into the nucleus or cytoplasm of cell. Digitonin, cholesterol-binding family of bacterial exotoxin, is one of the most frequently used agents for causing transient pores in the plasma membrane of cell, which is sufficient for the passive diffusion of proteins up to the size of 100 kDa (Adam et al., 1992; Walev et al., 2001; Geelen, 2005). However, the reactivity of digitonin depends on cell types and species (Miyamoto et al., 2008). Therefore, in the preliminary experiment, determining the optimal concentration of digitonin to PFFs was examined. As the result, the permeability of cells recovered after being exposed to 4 and 6 μg/mL of digitonin for 2 min were significantly elevated more than 90% (Figure 1A) (p<0.05). However, the viability of cells treated with 4 μg/mL of digitonin showed significantly higher than those in 6 μg/mL of digitonin (Figure 1B) (p<0.05). Considering permeability and viability of the cells after being treated with digitonin, 4 μg/mL of digitonin was determined to the optimal concentration to PFFs.
Determination of the optimal period of exposure to SOE
In order to determine the optimal period of exposure to SOE, the permeabilized cells pretreated with 4 μg/mL of digitonin were incubated in the extracts for 0, 1, 3, 5 or 7 h, respectively. The histone acetylation status of the SOE-treated cells was assessed using an antibody specific to the acetylated form of H3K9. As shown in Figure 2, the intensity of H3K9ac staining in the PFFs was increased after incubation of 5 h with the SOE. The intensity of H3K9ac staining in the cells was significantly elevated after treatment of SOE for 7 h (p<0.05). In the experiment, 7 h was chosen for the optimal period of exposure to SOE. The morphology of the pre-treating PFFs after being exposed to SOE for 7 h was also examined. The nuclei of the permeabilized cells treated with SOE were observed more swelled than those of non-treated cells (not shown).
Changes in DNA methylation and histone acetylation of PFFs exposed to SOE
Not only chromatin of undifferentiated cells retains more epigenetic marks associated with transcriptionally active genes, but also less epigenetic marks which are associated with transcriptionally repressed genes (Meshorer et al., 2006). Therefore, we assessed the levels of active mark (H3K9ac) and repressive mark (H3K9me3) in the PFFs after treatment with SOE. The intensity of H3K9ac staining in the PFFs was significantly increased after treatment with SOE for 7 h (Figure 3A and B) (p<0.05). In contrast to the intensity of H3K9ac, the intensity of H3K9me3 staining in the cells was significantly decreased after the treatment of SOE (Figure 4A and B) (p<0.05). We also proved these observations using FACS analysis and western blotting method. The intensity of H3K9ac staining in the PFFs exposed to SOE was increased (Figure 3C and 5), whereas the intensity of H3K9me3 in the cells after treatment with SOE was decreased (Figure 4C and 5). Thus, these results indicated that some of oocyte factors existed in SOE has the ability to remodel chromatin of porcine somatic cells.
Reactivation of pluripotency genes in PFFs after treatment of SOE
Reactivation of pluripotency genes in the cells following the treatment of SOE was examined. As shown in Figure 6, the SOE-treated cells were slightly induced expressions of pluripotent markers (Oct4, Nanog and Sox2). However, non-treated permeabilized cells did not express any pluripotency marker genes, whereas the pluripotency genes were highly expressed in porcine induced pluripotent stem cells (iPSCs) (Figure 6).
Effects of SOE on histone acetylation in SCNT embryos at the zygote stage
In order to examine the change in chromatin of SCNT embryos reconstructed by pre-treating PFFs with SOE to be used as nuclear donors prior to SCNT, the intensity of H3K9ac staining in porcine SCNT embryos was measured. In vitro fertilized (IVF), SCNT and SCNT zygotes reconstructed by using SOE-treated cells were examined using an antibody to H3K9ac. Interestingly, the intensity of histone acetylation in the zygote stage SCNT embryos reconstructed using by SOE-treated cells was similar to that of IVF embryos (Figure 7). However, the intensity of histone acetylation (H3K9ac) staining in porcine cloned embryos reconstructed using by SOE-treated cells was significantly increased as compared to that of SCNT embryos (p<0.05) (Figure 7).
Development of SCNT embryos reconstructed by pre-treating PFFs with SOE to be used as nuclear donors prior to SCNT
Based on the result, the in vitro developmental competence of porcine SCNT embryos reconstructed by using SOE-treated cells was examined. No difference was observed in the number of fused couplets that cleaved between the control and SOE-treated group (Table 2). However, there was a significant increase in the percentage of fused couplets that developed to the blastocyst stage in SOE-treated group (Table 2). The developmental competence of SOE-treated SCNT embryos to the blastocyst stage was significantly higher than that of the control (21.0% vs 13.8%) (p<0.05).
Cell viability in SCNT embryos at the blastocyst stage reconstructed by using SOE-treated cells
The number of cells in porcine SCNT embryos at the blastocyst stage by pre-treating PFFs with SOE to be used as nuclear donors was examined (Table 3). The overall number of porcine cloned embryos in SOE-treated group was significantly increased as compared to that of the control (23.5±2.5 vs 15.5±4.3) (p<0.05). In addition, the number of apoptotic cells in the SOE-treated cloned embryos was slightly decreased as compared to that in control cloned embryos (5.5±3.1 vs 8.0±2.8). There was a significant difference in the percentage of apoptotic cells between the control and SOE-treated group (51.6% vs 24.4%) (p<0.05).
Pluripotent gene expressions of SOE-treated cloned embryos at the blastocyst stage
We investigated that whether treatment of the permeabilized cells with the extracts prepared from SOE prior to their use as nuclear donors for SCNT affects expression of the pluripotent genes (Oct4, Nanog and Sox2) in porcine SCNT embryos at the blastocyst stage. As shown in Figure 8, the levels of pluripotent related genes expression in porcine cloned embryos reconstructed by using the SOE-treated cells were quite similar to those in IVF embryos as the control. However, Sox2, Nanog and Oct4 in the cloned embryos were significantly less expressed when compared to those in IVF and SOE-treated cloned embryos (p<0.05) (Figure 9).
Unique oocyte factors necessary for the successful reprogramming of differentiated cells have been explored since the report of Dolly the sheep (Wilmut et al., 1997). It is generally accepted that even though successful production of cloned offspring following somatic cell nuclear transfer (SCNT) occurs across a range of species, so far, the efficiency of development to term and survival remains low. Faulty development caused by SCNT has been attributed to incomplete or aberrant reprogramming of the transferred nuclei into the recipient environment (Rideout et al., 2001). A number of strategies to resolve the insufficient or incomplete epigenetic reprogramming occurred by SCNT have been continuously reported (Martin et al., 2006). In the present study, we focused on epigenetic modifications associated with reprogramming of somatic cells in extracts of interspecies oocytes prior to the use of donor cells introduced into the recipient oocyte.
According to previous studies, pre-treatment with Xenopus laevis oocyte extracts at the GV stage could convert reprogramming of differentiated cells into undifferentiated or pluripotent state (Hansis et al., 2004; Alberio et al., 2005). It was importantly considered to be permeabilized the somatic cells because the treatment of extracts without this procedure may results in little reprogramming efficiency (Miyamoto et al., 2008). Generally the subsequent reprogramming of somatic cells with oocyte extracts may depend on the permeability of cell types as well as the activity of extracts. The permeabilization of plasma membrane is required for nuclear transport of egg-derived factors. Streptolysin O (SLO) is one of the most frequently used agents to be permeabilized on the plasma membrane of cell. However, it was reported that SLO has the harmful effect on cell survival. In the preliminary experiment, 4 μg/mL of digitonin was able to be reversibly permeabilized on the plasma membrane of porcine fetal fibroblast cells (PFFs) with approximately 40% survival rates.
By the aid of the permeabilization, the treatment of Siberian sturgeon oocyte extracts (SOE) could induce epigenetic modifications of somatic cells ex-ovo. Our result has shown that the changes in both Histone H3 Lys-9 acetylation (H3K9ac: mark associated with active chromatin) and Histone H3 Lys-9 methylation (H3K9me3: mark associated with transcriptional repression) were induced by using the SOE for a brief time of incubation (7 h), which are associated with controlling heterochromatin organization. Following treatment with the SOE, the intensity of H3K9me3 staining was significantly decreased whereas the intensity of H3K9ac in both the PFFs and porcine SCNT embryos at the zygote stage was significantly increased. Interestingly, the changes in both H3K9ac and H3K9me3 staining after the SOE treatment showed similarity to those of epigenetic modifications induced by using amphibian oocyte extract (Bian et al., 2009; Rathbone et al., 2010). Further to the previous experiments, the level of H3K9ac in the PFFs treated with SOE was also significantly increased but the level of H3K9me3 was slightly decreased as observed in porcine induced pluripotent stem cells (iPSCs) using western blotting. These findings indicated that exposure to SOE for a brief period alters some epigenetic modifications (DNA demethylation and histone acetylation) of porcine somatic cells. This event is reminiscent of the atypical bivalent epigenetic signature of ES cells (Bernstein et al., 2006), which could promote reprogramming by resetting the memory of the somatic nuclei.
Among the pluripotent markers, Oct4 is well known as retaining demethylated state during cell division and fulfilling an auto-regulatory capacity (Maherali et al., 2008; Bian et al., 2009). We investigated that the expressions of pluripotency related genes (Nanog, Oct4, and Sox2) were slightly reactivated in porcine somatic cells after being treated with SOE in a brief time (7 h). On the other hand, Nanog was generally expressed during the incubation of amphibian oocyte extracts, however, Oct4 was shown to express after several days of the culture (Bian et al., 2009). In the study, Oct4 and Nanog were expressed following a brief period of exposure to SOE.
By the way, Oct4 and Sox2 are essential for maintaining pluripotency of ES cells (Niwa, 2007) and for establishing iPS cells (Takahashi et al., 2007). These genes were also reactivated in SOE-treated cells, exactly similar to be permeabilized with digitonin and then cultured with amphibian oocyte extracts in vitro (Miyamoto et al., 2007). These results suggest that the reversibly permeabilization system with digitonin can be used for the reactivation of pluripotent genes in somatic cell after co-culture with cellular or oocyte extracts. The expression of Nanog is reactivated by Oct4 and Sox2 (Niwa, 2007) and enhances reprogramming efficiency of somatic cells after cell fusion (Silva et al., 2006). Therefore, the expression of these pluripotent related genes may convert somatic cells to partially dedifferentiated state after treatment with extracts.
The cytoplasmic environment of the fully matured oocyte is an important factor influencing reprogramming capability of donor cells used for SCNT in mammals. As one of attempts to enhance the efficiency of SCNT, the somatic nuclei used as donor cells may be needed to reprogram preferentially by using cellular or oocyte extracts. In this experiment, in vitro developmental competence of porcine cloned embryos reconstructed by using pre-treating PFFs with the SOE to be used as nuclear donor prior to SCNT was examined. The in vitro development to the blastocyst stage in SCNT embryos reconstructed by using the SOE-treated cells was significantly higher when compared to that of the non-treated SCNT embryos. Based on the result of TUNEL, the total cell number of cloned embryos at the blastocyst stage in SOE-treated group was significantly increased as compared to that of SCNT embryos. In addition, the pluripotent related genes expressions in porcine cloned embryos reconstructed by using the SOE-treated cells were shown similar to those in IVF embryos. These results demonstrated that a combination of SCNT technique with the ex-ovo methods can improve the developmental competence and the quality of cloned embryos.
As a consequence of all experiments, the Siberian sturgeon oocyte extract (SOE) have an ability to convert porcine somatic cells into undifferentiated state following a brief period of incubation (7 h). Additionally, the in vitro development and quality of the blastocyst stage SCNT embryos were improved when produced by the use of SOE-treated cells as donor nucleus. The strategy of epigenetic remodeling by the treatment of SOE may contribute a useful tool for reprogramming of somatic cell nuclei. We need to exploit the nuclear reprogramming of differentiated cells into undifferentiated state induced by using interspecies cell or oocyte extracts. Furthermore, studies to select extract-treated cells for SCNT are required for optimized exploitation of the reprogramming ability of the extract.
This work was partly supported by the National Research Foundation of Korea funded by the Korean Government (NRF-2011-0013703) and Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009418022013 and PJ009117022013), Rural Development Administration, Republic of Korea.
Adam SA., Sterne-Marr R., & Gerace L. 1992. Nuclear protein import using digitonin-permeabilized cells. Methods Enzymol. 219:97–110.
Alberio R., Johnson A., Stick R., & Campbell KHS. 2005. Differential nuclear remodeling of mammalian somatic cells by Xenopus laevis oocyte and egg cytoplasm. Exp Cell Res. 307:131–141.
Bernstein BE., Mikkelsen TS., Xie X., Kamal M., Huebert DJ., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber SL., & Lander ES. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 125:315–326.
Bian Y., Alberio R., Allegrucci C., Campbell KHS., & Johnson A. 2009. Epigenetic chromatin marks in somatic chromatin are remodeled to resemble pluripotent nuclei by amphibian oocyte extracts. Epigenetics. 4:194–202.
Blau HM., & Blakely BT. 1999. Plasticity of cell fate: insights from heterokaryons. Semin Cell Dev Biol. 10:267–272.
Campman FA., & Eenennaam JP. 2007. The egg polarization index or PI. University of FLORIDA IFAS extension. 153:1–5.
Geelen MJ. 2005. The use of digitonin-permeabilized mammalian cells for measuring enzyme activities in the course of studies on lipid metabolism. Anal Biochem. 347:1–9.
Hansis C., Barreto G., Maltry N., & Niehrs C. 2004. Nuclear reprogramming of human somatic cells by Xenopus egg extract requires BRG1. Curr Biol. 14:1475–1480.
Håkelien AM., Landsverk HB., Robl JM., Skålhegg BS., & Collas P. 2002. Reprogramming fibroblasts to express T-cell functions using cell extract. Nat Biotechnol. 20:460–466.
Hochedilinger K., & Jaenisch R. 2002. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature. 415:1035–1038.
Landsverk HB., Håkelien AM., Küntziger T., Robl JM., Skålhegg BS., & Collas P. 2002. Reprogrammed gene expression in a somatic cell-free extract. EMBO Rep. 3:384–389.
Lee JH., & Campbell KHS. 2006. Effects of enucleation and caffeine on Maturation-Promoting Factor (MPF) and Mitogen- Activated Protein Kinase (MAPK) activities in ovine oocytes used as recipient cytoplasts for nuclear transfer. Biol Reprod. 74:691–698.
Maherali N., & Hochedlinger K. 2008. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell. 3:595–605.
Martin C., Beaujean N., Brochard V., Audouard C., Zink D., & Debey P. 2006. Genome restructuring in mouse embryos during reprogramming and early development. Dev Biol. 292:317–332.
Meshorer E., Yellajoshula D., George E., Scambler PJ., Brown DT., & Misteli T. 2006. Hyperdynamic plasticity of chomatin proteins in pluripotent embryonic stem cells. Dev Cell. 10:105–116.
Miyamoto K., Furusawa T., Ohnuki M., Goel S., Tokunuga T., Minami N., Yamada M., Ohsumi K., & Imai H. 2007. Reprogramming events of mammalian somatic cells induced by Xenopus laevis egg extracts. Mol Reprod Dev. 74:1268–1277.
Miyamoto K., Yamashita T., Tsukiyama T., Kitamura N., Minami N., Yamada M., & Imai H. 2008. Reversible membrane permeabilization of mammalian cells treated with digitonin and its use for inducing nuclear reprogramming by Xenopus egg extracts. Cloning Stem Cells. 10:535–542.
Morgan HD., Santos F., Green K., Dean W., & Reik W. 2005. Epigenetic reprogramming in mammals. Hum Mol Genet. 14:R47–R58.
Rathbone AJ., Fisher PA., Lee JH., Craigon J., & Campbell KHS. 2010. Reprogramming of ovine somatic cells with Xenopus laevis oocyte extract prior to SCNT improves live birth rate. Cell Reprogram. 12:609–616.
Rideout WM., Eggan K., & Jaenisch R. 2001. Nuclear cloning and epigenetic reprogramming of the genome. Science. 293:1093–1098.
Silva J., Chambers I., Pollard S., & Smith A. 2006. Nanog promotes transfer of pluripotency after cell fusion. Nature. 441:997–1001.
Tada M., Tada T., Lefebvre L., Barton SC., & Surani MA. 1997. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16:6510–6520.
Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., & Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131:861–872.
Takahashi K., & Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultured by defined factor. Cell. 126:663–676.
Tang S., Wang Y., Zhang D., Gao Y., Ma Y., Yin B., Sun J., Liu J., & Zhang Y. 2009. Reprogramming donor cells with oocyte extracts improves in vitro development of nuclear transfer embryos. Ani Reprod Sci. 115:1–9.
Taranger CK., Noer A., Sorensen AL., Hakelien AM., Boquest AC., & Collas P. 2005. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol Cell. 16:5719–5735.
Wakayama T., Perry ACF., Zuccotti M., Johnson KR., & Yanagimachi R. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature. 394:369–373.
Walev I., Bhakdi SC., Hofmann F., Djonder N., Valeva A., Aktories K., & Bhakdi S. 2001. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc. Natl. Acad. Sci USA. 98:3185–3190.
Wilmut I., Schnieke AE., McWhir J., Kindm AJ., & Campbell KHS. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature. 385:810–813.